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RNA replicationTheWest Nile virus (WNV) genome contains a single RNA-dependent RNA polymerase (RdRp) gene, which is
responsible for replication of the viral genome and, as such, is an important target for antiviral therapy. Viral
RdRps are known to lack proofreading capabilities and as a result viruses such asWNV exist as a mixture of viral
genotypeswithin an infection, enabling the virus to readily emerge and adapt to new host environments. To test
the consequences of subtle structural alterations remote from the RdRp active-site, the following single point
mutations were engineered in the WNV NS5 RdRp coding region: T363N, A365N, and T537I; these mutations
were selected in an effort to stabilize the secondary structural elements near the rNTP binding pocket of the
RdRp. Mutant viruses were tested in vitro on Vero, C6/36, Culex tarsalis and DF-1 cell types and in vivo in one
day old chickens and Culex pipiens mosquitoes. Plaque morphology was affected by each mutation and growth
and RNA replication kinetics were altered as well. Our results demonstrate that subtle alteration of the RdRp
protein away from the active site can have a signiﬁcant overall biological effect on WNV ﬁtness, and that this
effect can be host-dependent.
© 2012 Elsevier Inc. All rights reserved.Introduction
West Nile virus (WNV; Flaviviridae; Flavivirus) was introduced into
the United States more than a decade ago and now persists in local
transmission cycles throughout North America (Kramer et al., 2007;
Lanciotti et al., 1999). Unlike other ﬂaviviruses (i.e., St. Louis encephalitis
virus) which tend to cause geographically limited outbreaks, WNV has
proven to be a generalist in terms of viral ﬁtness, with the capacity to
infect and replicate in a broad array of arthropod and avian hosts. This
generalist nature has permitted the emergence and rapid dissemination
of WNV in diverse ecological niches. All ﬂaviviruses, including WNV,
contain a single-strand positive-sense RNA genome, encoding a single
polyprotein consisting of both structural (C, prM and E) and non-
structural (NS1, 2a–b, 3, 4a–b and 5) proteins. The WNV NS5 is a bi-
functional enzyme, with the N-terminal region consisting of the viral
methyltransferase responsible for type-1 RNA cap formation and the
C-terminal domain encoding the viral RNA-dependent RNA polymerase
(RdRp) responsible for the de novo synthesis of the viral genomeOH Arbovirus Laboratory, 5668
8 485 6669.
er).
rights reserved.(Nomaguchi et al., 2004; Zhang et al., 2008). Viral RdRps have the high-
est error rate (lowestﬁdelity) of all knownRNApolymeraseswith 0.1 to
1 nucleotide mutation per 10,000 bases copied (Domingo and Holland,
1994) or about 1mutation per genome copied forWNV,with a genome
length of just over 11 kilobases (kb).Wehave shown thatWNVexists as
a mutant spectrum within natural vectors and hosts and that mutant
spectrum breadth plays an important role in viral pathogenesis, ﬁtness,
and adaptability (Ciota et al., 2007a, 2007b; Fitzpatrick et al., 2010;
Jerzak et al., 2005, 2007). The low-ﬁdelity viral RdRp acting in concert
with a rapid viral replication cycle is most directly responsible for
the mutant spectrum phenomenon commonly seen in ﬂavivirus
infections.
The crystal structure of the WNV RdRp resembles the classic viral
RdRp architecture with thumb, palm and ﬁngers sub-domains. Overall,
the WNV RdRp structure displays many unique features when
compared to both other ﬂavivirus RdRps and more distantly related
RdRps (Malet et al., 2007). To date there have been published studies
to determine the basic mechanistic functions and molecular interac-
tions of WNV RdRp indicating that the polymerase domain is a prime
target for anti-viral drug development (Dong et al., 2008; Malet et al.,
2008; Nomaguchi et al., 2004; Zhang et al., 2008). However, the conse-
quence of altered polymerase function on mutant spectrum breadth,
and subsequently viral adaptation, evolution, and pathogenesis has
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the role of the RdRp in arboviralﬁtness and transmission in themosqui-
to and vertebrate hosts required for arbovirus maintenance is only
starting to be examined. A recent studywith Chikungunya virus (family
Togaviridae; genus Alphavirus) examined the effects of arboviral RdRp
mutation; where a single amino acid change that conferred mutagen
resistance in vitro also lowered the ﬁtness of the virus in its vector
Aedes aegypti (Coffey et al., 2011). Our objective in this study was to
begin to determine the role of the ﬂavivirus RdRp in viral ﬁtness
(i.e., the virus's ability to infect and replicate in a given host system)
by subtle alteration of the WNV NS5 structure below the RdRp active
site. We used computer modeling to determine where to incorporate
amino acid substitutions, with the following residue changes engi-
neered: NS5-T363N, NS5-A365N and NS5-T537I. Modeling indicates
that none of these residues is in direct contact with the incoming
rNTP, but instead they are positioned to stabilize residues below the
rNTP binding pocket around amino acids NS5-D541 and NS5-D668 via
hydrogen-bonding or van derWaals interactions (Figs. 1a–d). To deter-
mineWNVRdRp-mutant ﬁtness, each viruswas inoculated into various
in vitro and in vivo host systems. Mutants were found to possess their
own unique phenotype; all were attenuated when compared to the
parental WNV strain in vitro and signiﬁcant host-dependent attenua-
tion was observed in vivo in one day old chicks and Culex pipiens
mosquitoes. Therefore, we determined that subtle alteration of the
WNV RdRp structure can have signiﬁcant biological consequences
with regard to viral ﬁtness, and these consequences were found to be
host-dependent, suggesting a host-speciﬁc mechanism involving the
function of the viral RdRp.a
c
Fig. 1. The overall structure of WNV NS5 RdRp colored according to the polymerase sub-dom
side chain interactions of residues Asn363 (b), Asn365 (c) and Ile537 (d) with the remainde
active site but structurally support the loop containing motif A. Most of the polar (dashed lin
turn in RdRp motif A, which is involved in binding of magnesium ions and the incoming rN
coordinates (Malet et al., 2008).Results
Rationale for introduced mutations
There is currently a lack of knowledge regarding the relationship
between RdRp structure/function and viral ﬁtness in natural hosts.
Speciﬁcally, the role the RdRp plays in viral ﬁtness and transmissibility
in both vertebrate hosts and mosquito vectors of arboviruses is just
beginning to be explored. We sought to modify the region near motif
A in the WNV RdRp by introducing single amino acid changes in an
effort to strengthen interactions and remotely stabilize the active
site. Generally, the amino acid substitutions are conservative, but pos-
sess slightly longer side chains, and, therefore, a local strengthening of
hydrogen bond and van der Waals interactions is predicted. Residues
363 and 365 have been mutated to asparagine, whereby the longer,
polar side chain is poised to interact with carbonyl oxygen and back-
bone nitrogen atoms in a helical turn within RdRp motif A (residues
541–546) (Figs. 1b and c). Thr537 has been mutated to isoleucine
in an attempt to strengthen van der Waals interactions with a neigh-
boring Trp540 (Fig. 1d). Thus, the strengthening of side-chain/side-
chain interactions near RdRp motifs A and C is thought to result in
an overall stabilization of the WNV RdRp active site.
Assessment of plaque morphology
Upon initial titration of the RdRpmutant viruses, signiﬁcant reduc-
tion of plaque size was observed [pb0.01 for all mutants compared to
WNV- infectious clone (IC)]; where mean plaque diameters wered
b
ains (a). The RdRp active site is indicated as motifs A and C (black arrows). Detail of the
r of the WNV RdRp active site. Note that mutations are not directly located in the RdRp
es) or van der Waals (gray spheres) interactions are designed to stabilize a short helical
TPs. This ﬁgure was generated in PyMol using PDB entries 2HCN and 2HFZ as starting
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Fig. 2. Mutant plaque size reduction as compared to parental WNV-IC. Signiﬁcance for
all mutants as compared to WNV-IC (pb10−6) denoted with (*). Signiﬁcance for
A365N as compared to T363N and T537I (pb0.004) denoted with (†).
20 G.A. Van Slyke et al. / Virology 427 (2012) 18–243.3, 1.56, 0.7 and 0.4 mm for WNV-IC, T363N, T537I and A365N
respectively (Fig. 2).
NS5 mutant growth kinetics in vitro
In an effort to characterize growth kinetics in a variety of hosts
in vitro, primary stocks of RdRp mutant viruses along with the WNV-
IC were inoculated on four cell types: Vero (mammalian), C6/36
(Aedes albopictus), CxT (Culex tarsalis), and DF-1 (avian) (Fig. 3),
following infection at a multiplicity of infection (MOI) of 0.01. Statisti-
cal comparisons of growth kinetics of mutant viruses and WNV-IC by
t-test were completed at all time points. NS5 mutant viruses demon-
strated varying degrees of attenuation in all cell types tested (Fig. 3).
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Fig. 3. NS5 mutant growth kinetics in vitro in Vero (a), C6/36 (b), C. tarsalis (c) and DF-1 (d
Viral titers of NS5 A365N are signiﬁcantly lower thanWNV-IC at all time points in all cell line
to WNV-IC are denoted by * and †, respectively.signiﬁcantly lower titers (pb0.01) at 24 h post-inoculation (p.i.) and
A365N (pb0.01) grew to signiﬁcantly lower titers at all time-points
tested when compared to the WNV-IC. In C6/36 cells (Fig. 3b), all
mutant viruses, compared to the WNV-IC, grew to signiﬁcantly
lower titers at 48 h p.i. and NS5-T537I was signiﬁcantly attenuated
(pb0.05) at 24 and 48 h p.i. Again, NS5-A365N was signiﬁcantly
(pb0.01) attenuated at all time-points tested when compared to
WNV-IC growth kinetics. Similar results were obtained for growth
on CxT cells (Fig. 3c), where all mutant viruses grew to signiﬁcantly
lower titers at 48 h p.i. (pb0.02 for T363N and T537I; pb0.01 for
A365N). Mutant NS5-T537I also grew to signiﬁcantly lower titers at
72 h and 96 h (pb0.01) p.i.; and NS5-T363N was also attenuated at
72 h p.i. The growth of NS5-A365N virus was signiﬁcantly attenuated
(pb0.01) on CxT cells at 24 h, 48 h and 96 h post-inoculation. The
most dramatic levels of attenuated growth kinetics for NS5mutant vi-
ruses were seen in the avian DF-1 cell line (Fig. 3d), where all NS5mu-
tant viral growth was signiﬁcantly attenuated at all time-points
sampledwith the NS5-A365Nmutant again displaying themost atten-
uated growth phenotype.
RNA replication kinetics in vitro
In order to determine if RNA replication, was compromised as a
result of the engineered mutations; C6/36 cells were infected at a
MOI of 10 with primary stocks of WNV RdRp mutants and WNV-IC,
viron production in the supernatant was measured by plaque assay
at 8, 12 and 24 h p.i. and RNA copy numbers were determined for
each time-point by quantitative RT-PCR. The results at 24 h p.i.
(Fig. 4) show all WNV-NS5 mutant viruses are signiﬁcantly deﬁcient
in RNA replication when compared to the WNV-IC (pb0.05 for
T363N and T537I and pb0.01for A365N), in particular WNV-NS5Lo
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Fig. 4.WNV RNA replication on C6/36 cell culture. Conﬂuent monolayers of C6/36 cells
were infected at a M.O.I. of 10; supernatant was harvested and RNA extracted at 12 and
24 h post-infection. Real-time RT-PCR was performed to determine viral RNA copy
numbers. Signiﬁcant differences relative to WNV-IC (T363N pb0.02, A365N pb0.001
and T537I pb0.03) denoted with (*). Signiﬁcant differences relative to T363N
(pb0.001) and T537I (pb0.0005) denoted with (†).
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Fig. 5.WNV in vivo growth kinetics in day-old chickens (a) data points represent mean
serum titer of ﬁve chicks inoculated SC with 100 pfu virus, signiﬁcant difference rela-
tive to WNV-IC for all mutants denoted with (*) (pb0.03), signiﬁcant difference of
A365N relative to T363N and T537I denoted with (†), signiﬁcant difference of both
A365N and T363N relative to WNV-IC (pb0.0003) denoted with (‡), and signiﬁcant
difference of A365N relative to WNV-IC denoted with (§). Viral growth kinetics in C.
pipiensmosquitoes (b). Data points represent mean titer of ﬁve mosquitoes inoculated
IT with 10 pfu virus.
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compared to WNV-IC but also when compared to both WNV-NS5
T363N and T537I (pb0.01). Results for 8 and 12 h p.i. with respect
to RNA copy number were indistinguishable, therefore only the 12 h
p.i. time-point is represented in Fig. 4. Copy number data correlated
with infectious particles (pfu) detected (data not shown) for these
samples, where each mutant displayed a signiﬁcant titer reduction
(pb0.01) at 24 h p.i., when compared to WNV-IC, relative to its deﬁ-
ciency in RNA replication.
NS5 mutant growth kinetics in vivo
Viral growth kinetics in vitro do not always correlate with the
kinetics within host organisms. Therefore we conducted viremia
studies in one day-old chickens and evaluated viral growth in C. pipiens
mosquitoes. One day old chickenswere inoculatedwith 100 pfu of virus
sub-cutaneously in the neck and ﬁve chicks per virus were bled by the
brachial vein every 24 h for up to 120 h post-inoculation (p.i.). Viral
titers were determined by plaque assay on Vero cells. Replicative ﬁtness
of WNV-NS5 mutants in vivo in chickens and mosquitoes was found to
be host-dependent (Fig. 5). Varying degrees of attenuation of viremia in
one day-old chickens of all NS5mutant viruseswas observed compared
to the WNV-IC (Fig. 5a). At one day p.i. viremia was attenuated for all
mutants. At day 2 p.i., peak viremia for WNV-IC, all mutant viruses
were signiﬁcantly attenuated (pb0.01); at day 3 p.i. both NS5-T363N
and A365N were signiﬁcantly attenuated. The largest difference in
serum titers among NS5 mutants was seen at day 2 p.i., where NS5-
A365N was signiﬁcantly attenuated compared to both T363N and
T537I. Consensus sequencing of the NS5 region of RNA extracted from
day 5 p.i. chick serum conﬁrmed that there was no detectable reversion
of mutant viruses.
Viral growthwasmeasured in C. pipiensmosquitoes (Fig. 5b), an im-
portant urban vector ofWNV, byway of intrathoracic (IT) inoculation of
10 pfu of virus and sampling at days 1–5, 8, 14, and 21 p.i. Surprisingly,
none of the mutant viruses differed signiﬁcantly in growth kinetics
when compared to the WNV-IC or each other. These results are in
contrast to what was seen in vitro in both mosquito cell types (C6/36
and CxT) where all NS5 mutant viruses displayed varying degrees of
attenuation. Consensus sequencing of the NS5 region of RNA extracted
from day 21 p.i. mosquito homogenate conﬁrmed no detectable rever-
sion of mutant viruses.
Discussion
The arboviral RdRp is responsible for the replication of the viral
genome and the generation of the mutant spectrum, which hasproven to be important in arboviral ﬁtness, adaptability and patho-
genesis in a host-dependent manner (Ciota et al., 2007a, 2007b;
Fitzpatrick et al., 2010; Jerzak et al., 2005, 2007). The ﬂavivirus
RdRp is considered a prime target for new antiviral drug therapy, as
the mammalian hosts of these viruses do not possess such a polymer-
ase (Cerutti, 2006); however, the speciﬁc mechanisms governing the
role of the RdRp in viral ﬁtness, transmission, pathogenesis and host
adaptation have only begun to be explored. In order to evaluate the
consequence of altered polymerase structure on the infectivity,
growth and replication of WNV in relevant hosts we constructed
three NS5-RdRp mutant WNV strains: NS5-T363N, A365N and T537I
each possessing a structurally plausible single amino acid change,
some 15 Å away from the conserved aspartates in the RdRp active
site. Initially signiﬁcant reductions in plaque size were noted for all
mutant viruses, in particular mutant NS5-A365N (Fig. 2). In vitro
assessment of growth kinetics in relevant host-type cell lines demon-
strated signiﬁcant attenuation of varying degrees for all mutant viruses,
again particularly with NS5-A365N (Fig. 3).
In day-old chickens, viremia of NS5 mutants correlated with results
in cell culture growth assays, particularly DF-1 cells, where all mutants
are signiﬁcantly attenuated, NS5-A365N most signiﬁcantly. Typically
peak WNV viremia titers are seen at day 2 p.i. in chicks, yet for all NS5
mutants peak titers were not reached until 3 to 4 days p.i. and no mu-
tant reached the same peak titer as the parental virus, WNV-IC
(Fig. 5a). These results are consistent with a signiﬁcant decrease in
viralﬁtness formutant viruses, due to the structural changes introduced
by our point mutations.
To assess the impact of the point mutations on viral RNA replication,
quantitative RT-PCR assays were performed on supernatant collected
Table 1
WNV NS5 mutations.
Amino acid changea Codon positiona Codon change
T363N 1087–9 ACG→AAC
A365N 1093–5 GCT→AAT
T537I 1609–11 ACA→ATC
a Position number for amino acid and nucleotide codons based on NS5 sequence.
22 G.A. Van Slyke et al. / Virology 427 (2012) 18–24from infected C6/36 cell cultures 12 h and 24 h p.i (Fig. 3). The results
demonstrate that all mutant viruses are signiﬁcantly deﬁcient in RNA
replication when compared to WNV-IC at 24 h, and mutant A365N is
most signiﬁcantly deﬁcient. The number of infectious particles for
each virus at 12 and 24 h p.i. directly correlates with the magnitude of
RNA replication deﬁciency, indicating a defect in RNA replication
brought about by the engineered point mutations as the cause of the
signiﬁcantly attenuated growth characteristics of these mutant viruses
both in vitro and in day-old chickens. Confounding this conclusion is
the ﬁnding that all mutant viruses, particularly A365N, were equally
able to infect and replicate in a natural mosquito vector, C. pipiens, in
contrast to in vitro growth kinetics on two mosquito cell lines (Figs. 3a
and b) where signiﬁcant attenuation was observed for mutant A365N
at 24, 48, 72 and 96 h p.i. This result highlights the importance of vali-
dating data obtained through cell culture assay in vivo in natural
hosts. Moreover, when compared to viremia kinetics in day-old
chickens, this result is indicative of a host-speciﬁc mechanism at the
level of the RdRp as a determinant of successful viral infection and
replication.
Single point mutations of the viral RdRp have previously been
shown to confer substantial biological consequences; a single pointmu-
tation in PV 3Dpol (G64S) signiﬁcantly decreased viral pathogenicity
and constrainedmutant swarm composition by increasing RdRpﬁdelity
(Pfeiffer and Kirkegaard, 2005; Vignuzzi et al., 2006, 2008). Inspection
of various (complete) PV 3Dpol and related picornavirus RdRp struc-
tures and experimental data suggests that this mutation near RdRp
motif A changes local interactions and can modify the stability and
kinetics of the active site (Arnold et al., 2005). A single amino acid mu-
tation in the foot-and-mouth disease virus (Picornaviridae; Aphthovirus)
polymerase catalytic site was found to confer resistance to the nucleo-
side analog ribavirin without consequence to viral growth or polymer-
ase ﬁdelity (Arias et al., 2008; Sierra et al., 2007). However, the
consequence of such mutations on the ﬂavivirus RdRp has not been
examined. The loop that harbors the mutations we inserted near motif
A of the WNV NS5 is located on the surface of the RdRp domain near
the ﬁngers/palm sub-domain junction. Surface-exposed loops are
found in similar positions in ﬂavivirus, picornavirus and other related
RdRp structures (Malet et al., 2008). We suspect that this region could
not only be involved in stabilizing residues in the polymerase active
site, but could also serve as a module that interacts with other replicase
components (MTase, helicase etc.) and possibly even host-factor
proteins. Positions NS5-363 and 365 are located in the ﬁngers subdo-
main and are within a signature region shown for DENV to be a func-
tional nuclear localization sequence known as “bNLS” (Brooks et al.,
2002; Forwood et al., 1999). DENV NS5 has been shown to localize to
the nucleus of infected cells, however, WNV NS5 is not known to local-
ize to the nucleus (Malet et al., 2008). The bNLS region of DENV-2 has
also been shown to directly interact with the c-terminus of the helicase
(NS3) component of the replicase complex (Johansson et al., 2001), the
structures of the WNV and DENV bNLS region within the RdRp are
nearly identical (Malet et al., 2008), therefore, a putative mechanism
for the deﬁciencies displayed for mutants T363N and A365N could be
a disruption of optimal interactions of the replicase complex. Further
biochemical studies are needed to conﬁrm this mechanism. In addition,
the Thr residue at position 363 has been conserved across all ﬂavi-
viruses sequenced thus far (Davidson, 2009) and our results suggest
that even a conservative change at this position can have a signiﬁcant
negative biological effect at the level of RNA replication.
Elements within the bNLS/Motif A region of the RdRp are thought
to play an important role in overall pol structure (Davidson, 2009;
Malet et al., 2008) and the most dramatic structural change to the
RdRp was predicted to be mutant A365N; as a result this mutant dis-
played severe and signiﬁcant phenotypic effects on cell culture and in
chickens. More interesting is that this attenuation did not carry over
in vivo to the mosquito vector C. pipiens, despite having signiﬁcant de-
ﬁciencies in RNA replication and growth in A. albopictus and C. tarsalismosquito cell lines. A possible explanation for this could be a host-
speciﬁc interaction between the viral RdRp/replicase complex and
vector cell machinery which allows the virus to function optimally
despite a sub-optimal structure. Involvement of host-factors in
this particular region of the WNV RdRp could explain the host-
dependent effects seen in this study. Thus far studies have shown
that the recruitment of host proteases in both the insect and verte-
brate is required for viral polyprotein processing and a recent study
demonstrated at least 18 mosquito proteins can interact with the
WNV and DENV envelope, capsid, NS2a, and NS4b viral proteins in
mosquito cell culture (Colpitts et al., 2011). However, little is
known about host-factors that may interact with the viral replicase
complex.
Our results represent an important investigation of the role of
WNV RdRp structure in the growth kinetics and RNA replication of
an arbovirus and demonstrate that subtle, single point mutations in
the ﬂavivirus RdRp can have profound phenotypic consequences.
Future studies will help elucidate the speciﬁc mechanisms of attenu-
ation and host protein interactions which may be enhancing viral
replication in the mosquito vector and also determine how these
consequences might relate to mutant swarm composition.Materials and methods
Viruses
The West Nile virus infectious clone (WNV-IC) virus was generated
from an infectious cDNA clone based on WNV strain 3356
(AF404756). Methods for clone manipulation and rescue of infectious
WNV are as described previously (Shi et al., 2002). Using PyMOL, mu-
tantWNVNS5-T363N, A365N, T537I were designed by close inspection
of the WNV RdRp crystal structure (Fig. 1) superimposed with other
structurally related and appropriately aligned RdRps from Dengue
virus (DENV), Foot and mouth disease virus (FMDV) and Poliovirus
(PV). The mutants shown in Table 1 were generated by site-directed
mutagenesis (SDM) of the WNV-IC using the QuikChange XLII SDM kit
(Stratagene, La Jolla, CA) as per the manufacturer's protocol. Mutant
WNV-IC DNA was then ampliﬁed in E. coli and plasmid harvested by
Highspeed Midiprep (Qiagen, Valencia, CA). Full genome sequencing
of NS5 mutant WNV-IC plasmids indicated no other mutations were
present except those engineered.
All mutant and control WNV-IC plasmids were transcribed using
the MEGAscript kit (Ambion, Austin, TX) and assembled as per man-
ufacturer's protocol. Resulting RNA was puriﬁed with the MEGAclear
kit (Ambion). Wild-type WNV-IC RNA and mutant RNAs: WNV-NS5
T363N, NS5 A365N, NS5 T537I, were electroporated into C6/36 cells
using a GenePulser (BioRad, Hercules, CA). Supernatants were collected
from days 3 to 7 post-transfection; these primary viral stockswere used
as inocula for all viral growth experiments. WNV infectious particles
were quantiﬁed by plaque assay on Vero cells.
In order to determine the stability of the engineered mutations all
mutant viruses were subjected to an independent blind passage series
and sequenced after 3 blind passages in C6/36 cells, no reversions
were detected. Passaged viruses were not used in any of the viral
growth studies described herein.
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African greenmonkey kidney cells (Vero, ATCC #CCL-81); A. albopic-
tus mosquito cells (C6/36, ATCC #CRL-1660); Chicken embryo ﬁbro-
blast cells (DF-1, ATCC #CRL-12203); and C. tarsalis (CxT) cells,
originally from UC Davis and kindly provided by A. Brault were used
for in vitro viral growth assays.Experimental hosts
Speciﬁc pathogen free (SPF) chicken eggs (Gallus gallus) were
obtained from Sunrise Farms (Catskill, NY) and hatched in a brooder
incubator (G.Q.C. Brand, GA) at the Arbovirus Laboratory. Colonized
C. pipiens mosquitoes were originally derived from larvae collected
in Pennsylvania and maintained at the Wadsworth Center Arbovirus
Laboratories since 2004. Rearing procedures and conditions for
experimental mosquitoes are described elsewhere (Ebel et al., 2004).Plaque size determination and in vitro growth kinetics
Plaque phenotype of primary virus stocks of WNV-IC and NS5 mu-
tant viruses was determined by plaque assay on Vero cells. At least 10
plaques per strain were measured using Zeiss Axioscope software.
Statistical comparisons of plaque size differences were done by paired
t-test analysis.
Viral growth kinetics were determined using conﬂuent Vero, C6/
36, CxT and DF-1 cell monolayers in 6-well plates following inoculation
with amultiplicity of infection (MOI) of 0.01 of each primary virus stock
in triplicate. After 1 h of incubation inoculumwas removed and mono-
layers were washed and overlaid with 3 ml of maintenance media. Su-
pernatant samples were taken at 24, 48, 72 and 96 h post-inoculation
and titrated on Vero cells in duplicate by plaque assay. Growth curves
were plotted using mean titer per time-point.
For one step growth kinetic analysis, C6/36 cell monolayers in 6-
well plates were inoculated with a MOI of 10 in triplicate for eachmu-
tant virus and WNV-IC primary virus stock. Absorption of the virus
was allowed for 1 h at 28 °C, then wells were washed and overlaid
with media; supernatant samples were taken at 8, 12, and 24 h
post-inoculation. Samples were titrated on Vero cells in duplicate by
plaque assay; RNA was extracted from all supernatants using the
QiAmp viral RNA spin columns (Qiagen) and used for RNA copy num-
ber analysis by TaqMan (Applied Biosystems, Carlsbad, CA) using a
primer/probe set speciﬁc to the WNV E gene (Shi et al., 2001); reac-
tions were set up as per the manufacturer's protocol. Comparative
differences in copy number were analyzed by t-test using geometric
mean values.Viremia kinetics in chickens
One day old SPF chickens in groups of 5 were infected by sub-
cutaneous inoculation with 100 pfu of primary stock virus in 0.1 ml
animal inoculation diluent (endotoxin free phosphate-buffered saline
supplemented with 1% FBS) per group, along with 2 mock inoculated
chickens (diluent only). All groups were housed separately in adja-
cent cages. Chickens were bled from the brachial vein at days 1
through 4 post-inoculation and 50 μl of blood was collected via capil-
lary action into serum separator tubes, separated, aliquoted, and used
to determine the infectious WNV titer by plaque assay on Vero cells.
On day 5 post-inoculation, chicks were given a lethal dose of Sleep-
away (Fort Dodge Animal Health, Fort Dodge, IA) and cardiac punc-
ture was performed to collect blood. Serum was used to determine
the infectious WNV titer by plaque assay on Vero cells and to extract
viral RNA using Qiamp viral RNA spin columns (Qiagen) for subse-
quent sequence veriﬁcation.Viral growth kinetics in mosquitoes
Fifty female C. pipiensmosquitoes per virus were infected by intra-
thoracic inoculation with 10 pfu primary virus stock each. Mosquitoes
were held for 21 days at 27 °C and maintained on a 10% sucrose solu-
tion. Five mosquitoes were harvested on days 1 through 5, 7, 14, and
21 post-inoculation for each virus. Bodies were homogenized and
mosquito debris was removed by centrifugation, the resulting super-
natant was used for titration by plaque assay on Vero cells. An aliquot
of day 21 homogenate was taken for RNA extraction with Qiamp viral
RNA kit (Qiagen) and used for subsequent sequence veriﬁcation.
NS5 Sequencing
In order to dismiss the possibility of reversion, all mutant viruses
were subjected to NS5 sequencing after in vitro and in vivo analysis.
RNA extracted from day 5 chick serum, day 21 mosquito harvest,
day 4 cell culture supernatant were subjected to reverse transcription
(RT) and polymerase chain reactions (PCR) using the Qiagen One-
Step RT-PCR kit (Qiagen) with 3 primer sets encompassing the NS5
RdRp region (sequences available upon request). All sequencing was
carried out at the Wadsworth Center Applied Genomics Technology
Core (WCAGTC) on an ABI 3100 or 3700 automated sequencer (Applied
Biosystems).
Full genome consensus sequencing
To verify the presence of only the desired mutations, full genome
sequencing was performed on primary virus stocks of all NS5 mutant
WNV created by SDM, the full genome was ampliﬁed by RT-PCR in 10
overlapping fragments using one-step RT-PCR (Qiagen). A complete
list of ampliﬁcation and sequencing primers is available from the author
upon request. Consensus sequencing was performed as previously
described (Davis et al., 2005).
Sequence analysis
Sequences were compiled and edited using the SeqMan module of
the DNAStar software package (DNAStar, Inc., Madison, WI) and a min-
imum of two-fold redundancy throughout each clone or consensus
fragment was required for sequence data to be considered complete.
Molecular modeling
Polymerase crystal structures of WNV, DENV, Poliovirus and Foot-
and-mouth disease virus were superimposed using the program
PyMOL (http://www.pymol.org) and backbone-dependent side chain
rotamers in the Mutagenesis Wizard used to introduce mutations. Any
steric clashes were removed through manual adjustments followed by
energy minimization implemented in the program NAMD2 (http://
www.ks.uiuc.edu/Research/namd).
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